藥物成份

共有 21216 個藥物成份

Antimony Potassium Tartrate contains not less than 99.0% and not more than 103.0% of C8H4K2O12SB2・3H2O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Antsense Control (N) III：D-glucose 0.12%\nAntsense Control (H) III：D-glucose 0.4%\nAntsense Control (L) III：D-glucose 0.04%\nAntsense Calibrator III：D-glucose 0.15%

• 關聯藥證數量: 1

Apis mellifera, Vespula spp. Dolichovespula maculata \nPolistes spp. Dolichovespula arenaria Blatella germanica Aedes communis Chironomus thummi(C. riparius) Vespa crabro Solenopsis invicta \nCladotanytarsus Lewisi Trogoderma angustum (Solier) \nBombyx mori Gasterophilus intestinalis Tabanus spp.

• 關聯藥證數量: 1

Apixaban contains not less than 98.0 % and not more than 102.0 % of C25H25N5O4, calculated on dried substance.

• 關聯藥證數量: 1

Apixaban contains not less than 98.0% and not more than 102.0% of C25H25N5O4, calculated on anhydrous basis.

• 關聯藥證數量: 1

Apixaban contains not less than 98.0% and not more than 102.0% of C25H25N5O4, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Apo B Auto？N Daiichi\nBuffer Solution: Tri buffer (pH7.2) 100mmol/L\nMACROGOL 4000\nAntibody: antihuman apolipoprotein B\npolyclonal antibody(from goat) 10U/mL\nApo B Auto？N Daiichi Calibrator:\nHuman Serum

• 關聯藥證數量: 1

Apo C-II Auto？N Daiichi\nBuffer\nAntibody\nApo Auto？N High Calib CE：Serum、內含五種不同濃度ApoC.

• 關聯藥證數量: 1

Apo C-III Auto N DAIICHI 1：\nTris buffer (pH8.5) 100mmol/L\nMACROGOL\nApo C-III Auto N DAIICHI 2：\nantihuman apolipoprotein C-III polyclonal antibody 10U/mL\nbuffer

• 關聯藥證數量: 1

Apo E Auto．N”DAIICHI”(1) \nTris buffer (pH8.5) 100mmol/L\nMACROGOL\nApo E Auto．N”DAIICHI” (2)\nantihuman apolipoprotein E polyclonal antibody 10U/mL\nbuffer\n \n

• 關聯藥證數量: 1

ApoB Reagent containing:\nReactive IngredientsReagent 1 (R1): NoneReagent 2 (R2): Goat antisera to human apolipoprotein B Other IngredientsReagent 1 (R1): Preservative, polymer, buffer, inorganic salt Reagent 2 (R2): Preservative, buffer, inorganic salt Calibrator Kit 22 containing: CAL1-5, 0.5 mL each.ApoB Performance Verifiers I: containing 6 vials, 0.5 mL each.

• 關聯藥證數量: 1

Approximate Formula Per Liter Purified Water Pancreatic Digest of Casein 7.5g Selected Meat Peptone 7.5g Corn Starch 1.0g Dipotassium Phosphate 4.0g Monopotassium Phosphate 1.0g Sodium Chloride 5.0g Agar 12.0g Hemoglobin 10.0g IsoVitaleX Enrichment 10.0 mL V-C-N Inhibitor 10.0 mL Trimethoprim Lactate 5.0mg

• 關聯藥證數量: 1

Approximate Formula Per Liter Purified WaterPancreatic Digest of Casein…………………………………..7.5 gSelected Meat Peptone………………………………………..7.5 gCorn Starch……………………………………………………1.0 gDipotassium Phosphate……………………………………….4.0 gMonopotassium Phosphate……………………………………1.0 gSodium Chloride………………………………………………5.0 gAgar…………………………………………………………..12.0 gHemoglobin…………………………………………………..10.0 gIsoVitaleX Enrichment……………………………………….10.0 mL

• 關聯藥證數量: 1

Approximate Formula Per Liter Purified Water\nChromopeptone 10.0g\nGlucose 20.0g\nChromogen Mix 2.0g\nChloramphenicol 0.5g\nAgar 15.0g

• 關聯藥證數量: 1

Approximate Formula* Per 600 ml Purified Water: 2.5g Monopotassium Phosphate, 0.24 g Magensium Sulfate, 0.6 g \nSodium Citrate, 3.6 g L-Asparagine, 30.0 g Potato Flour, 0.4 g Malachite Green, 12.0 ml Glycerol, 1000.0 ml Whole egg.\n

• 關聯藥證數量: 1

Approximate Formula*Per Liter\nYeast Extract 10.0g\nFerric Pyrophosphate 0.25g\nACES Buffer 10.0g\nCharcoal, Activated 2.0g\nAlpha-Ketoglutarate 1.0g\nAgar 15.0g

• 關聯藥證數量: 1

Aqueous buffer solution containing ammonia, ethanol and sodium bicarbonate and Preservatives

• 關聯藥證數量: 1

Arachidonic Acid, 3 x 0.5 ml

• 關聯藥證數量: 1

Architect Anti-HBe Reagent,100 or 400 Tests Architect Anti-HBe Reagent Kit ．Microparticles 1 or 4 bottle(s) (6.6ml) Microparticles:Antibody to Hepatitis B e Antigen (mouse, monoclonal) coated microparticles in phosphate buffer with protein stabilizer. Minimum concentration:0.08% solids. Preservatives:ProClin 300 and other antimicrobial Agents. ．Conjugate 1 or 4 bottle(s) (5.9ml) Conjugate: Acridinium-labeled antibody to Hepatitis B e Antigen (mouse, monoclonal) conjugate in MES buffer with protein stabilizer. Minimum concentration:0.08 μg/ml. Preservative:ProClin 300. ．Neutralizing reagent 1 or 4 bottle(s) (5.9ml) Neutralizing Reagent:Hepatitis B e Antigen (recombinant DNA) in TRIS buffer with protein stabilizer. Minimum concentration:6.7 PEI U/ml. Preservatives:Antimicrobial Agents. Architect HBeAg Controls ．2 bottles (8ml each) of ARCHITECT Anti-HBe are recalcified human plasma. Archi

• 關聯藥證數量: 1

Architect Anti-HCV Reagent Kit1.1 or 4 Bottle(s) (6.6ml per 100 test bottle /27.0ml per 500 test bottle) HCV (E.coli, Yeast, Recombinant) antigen coated microparticles In MES buffer. Minimum concentration:0.14% solids.2.1 or 4 Bottle(s) (5.9ml per 100 test bottle /26.3ml per 500 test bottle) conjugate:Murine anti-IgG/anti-IgM acridinium labeled conjugate in MES buffer. Minimum concentration: (IgG) 8ng/ml (IgM) 0.8 ng/ml3.1 or 4 Bottle(s) (10.0ml per 100 test bottle/50.9ml per 500 test bottle) anti-HCV assay diluent containing TRIS buffer with protein stabilizer.Architect I Pre-Trigger Solution:Pre-Trigger solution containing1. 32% (W/V) hydrogen peroxide.Architect I Trigger Solution:Trigger solution containing 0.35 NSodium hydroxide.Architect I Wash Buffer:Wash buffer containing phosphate bufferedSaline solution.Architect Anti-HCV Calibrators:1 bottle (4ml each) of ArchitectAnti-HCV calibrator is prepared in recalcified human plasma(inactivated);reactive for a

• 關聯藥證數量: 1

Architect HBeAg Reagent Kit, 100 or 400 Tests Architect HBeAg Reagent Kit ．Microparticles 1 or 4 bottle(s) (6.6ml) Microparticles:Antibody to Hepatitis B e Antigen coated microparticles. ．Conjugate 1 or 4 bottle(s) (5.9ml) Conjugate: Acridinium-labeled antibody to Hepatitis B e Antigen conjugate. ．Assay Diluent 1 or 4 bottle(s) (3.9ml) Assay Diluent:Phosphate buffer with recalcified human plasma. Architect HBeAg Controls ．1 bottle (8ml) of Architect HBeAg Negative Control. ．1 bottle (8ml) of Architect HBeAg Positive Control. Architect HBeAg Calibrator ．1 bottle (4ml) of Calibrator 1 ．1 bottle (4ml) of Calibrator 2 Other solutions 1.Architect Pre-Trigger Solution 2.Architect Trigger Solution 3.Architect Wash buffer

• 關聯藥證數量: 1

Architect HBsAg Reagent Kit1.1 or 4 Bottle(s) (6.6ml per 100 test bottle /27.0ml per 500 test bottle) Anti-HBs (Mouse, Monoclonal IgM, IgG) Coated microparticles in MES buffer with protein stabilizers. Minimum Concentration:0.0675% solids.2.1 or 4 Bottle(s) (5.9ml per 100 tese bottle /26.3ml per 500 test bottle) Conjugate:Anti- HBs (Goat, IgG) Acridinium-LabeledConjugate in MES buffer with protein stabilizersMinimum concentration:0.25u g/mlArchitect HBsAg Manual Diluent:1 Bottle (100ml) Architect HBsAgManual diluent containing recalcified human plasma, nonreactiveFor HBsAg, HIV-1 Ag, anti-HIV-1/HIV-2, and anti-HBs.Architect i Pre-Trigger Solution:Pre-Trigger solution containing1.32% (W/V) hydrogen peroxide.Architect i Trigger Solution: Trigger solution containing 0.35NSodium hydroxide. Architect i wash buffer:Wash buffer containing phosphate bufferedSaline solution. Preservatives:Antimicrobial agent.Architect HBsAg calibrators:2 bottles (4ml each) of Architec

• 關聯藥證數量: 1

Arginine (L-Arginine) contains not less than 98.5% and not more than 101.0% of C6H14N4O2, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Arginine hydrochloride (L-Arginine Monohydrochloride) contains not less than 98.5% and not more than 101.0% of (C6H14N4O2-HCl), calculated with reference to the dried substance.

• 關聯藥證數量: 1

Aripiprazole contains not less than 98.0% and not more than 102.0% of C23H27Cl2N3O2, calculated on the dried substance.

• 關聯藥證數量: 1

Aripiprazole contains not less than 98.0% and not more than 102.0% of C23H27Cl2N3O2.

• 關聯藥證數量: 1

Aripiprazole contains not less than 98.5% and not more than 101% of C23H27Cl2N3O2, calculated on the dried basis.

• 關聯藥證數量: 1

Array Lipoprotein (a) Reagent:\nLPA Antibody\n(polyclonal anti-lipoprotein(a) antibody; rabbit 5.0 mL per vial.\nLipoprotein(a) Calibrator (LPA CAL):\nFresh frozen human plasma that has been defibrinated and processed, 1.0 mL per vial.\n

• 關聯藥證數量: 1

Arsenazo III 0.136 mmol/L\nSodium Azide 0.05%\nBuffer\nSurfactant

• 關聯藥證數量: 1

Arsenazo III 0.136 mmol/L\nSodium azide 0.05%

• 關聯藥證數量: 1

Arsenazo III：0.17 mmol/L

• 關聯藥證數量: 1

Articaine hydrochloride Assay (Titration, wt%): 98.5 per cent to 101.0 per cent (dried substance).

• 關聯藥證數量: 1

Ascensia Elite Blood Glucose Test Strips: 29.1% w/w glucose oxidase (Aspergillus niger, 20 U/mg), 32.0% w/w potassium hexacyanoferrate (III), 38.9% w/w nonreactive ingredients \nAscensia Elite Control Solutions: glucose (% w/w) 0.07 (low), 0.10 (normal), 0.25 (high)

• 關聯藥證數量: 1

Ascorbate oxidase ≧ 1.0 kU/l

• 關聯藥證數量: 1

Ascorbic Acid 90% granulation

• 關聯藥證數量: 1

Ascorbic Acid 99.0~100.5%

• 關聯藥證數量: 1

Ascorbic Acid contains less than 99.0% and not more than 100.5% of C6H8O6

• 關聯藥證數量: 1

Ascorbic Acid contains not less than 99.0 percent and not more than 100.5 percent of C6H8O6

• 關聯藥證數量: 1

Ascorbic Acid contains not less than 99.0% and not more than 100.5% of C6H8O6.

• 關聯藥證數量: 1

Ascorbic Acid content 99.0% to 100.5%

• 關聯藥證數量: 1

Ascorbic Acid：0.3% w/w 2,6-dichlorophenolindophenol；99.7% w/w buffer and non-reactive ingredients Glucose：1.5% w/w glucose oxidase；0.5% w/w peroxidase；10.0% w/w potassium iodide；75.0% w/w buffer；13% w/w non-reactive ingredients. Bilirubin：0.5% w/w 2,4-dichloroaniline diazonium salt；99.5% w/w buffer and non-reactive incredients. Ketone：5% w/w sodium nitroprusside； 95% w/w buffer

• 關聯藥證數量: 1

Ascorbic acid contains not less than 99.0% and not more than 100.5 % of C6H8O6.

• 關聯藥證數量: 1

Ascorbic acid: 19 mM、\nFerene: 0.56 mM、\nFerric chloride: 0.02 mM、\nCitric acid: 0.2 mM、\nAcetate Buffer: 500 mM、\nThiourea: 33mM、\nTris buffer: 200 mM、\nDC84: a liquid bovine serum albumin-based product.

• 關聯藥證數量: 1

Ascorbic acid: 2, 6-dichlorophenolindophenol 0.7%\nBilirubin: diazonium salt 3.1%\nBlood: tetramethylbenzidine-dihydrochloride 2.0% isopropylbenzol-hydroperoxide 21.0%\nGlucose: glucose oxidase 2.1%, peroxidase 0.9%, o-tolidine-hydrochloride 5.0%\nKetone: sodium nitroprusside 2.0%\nLeucocytes: carboxylic acid ester 0.4%; diazonium salt 0.2%\nNitrite: tetrahydrobenzo [h] quinolin-3-ol 1.5%; sulfanilic acid 1.9%\npH: methyl red 2%, bromothymol blue 10%\nProtein: tetrabromophenol blue 0.2%\nSpecific Gravity: bromothymol blue 2.8%\nUrobilinogen: diazonium salt 3.6% \n

• 關聯藥證數量: 1

Ascorbic acid：2,6-dichlorophenolindophenol 0.7% Bilirubin：diazonium salt 3.1% Blood：tetramethylbenzidine-dihydrochloride 2.0%, isopropylbenzol-hydroperoxide 21.0% Glucose：glucose oxidase 2.1%; peroxidase 0.9%;o-tolidine-hydrochloride 5.0% Ketones：sodium nitroprusside 2.0% Leucocytes：carboxylic acid ester 0.4%; diazonium salt 0.2% Nitrite：tetrahydrobenzo﹝h﹞quinolin-3-o 1.5%; sulfanilic acid 1.9% pH：methyl red 2.0%; bromothymol blue 10.0% Protein：tetrabromophenol blue 0.2% Specific Gravity：bromothymol blue 2.8% Urobilinogen：diazonium salt 3.6%

• 關聯藥證數量: 1

Ascorbic、Ferene、Microbial Inhibitor、Thiourea、Acetate Buffer、Surfactant

• 關聯藥證數量: 1

Aspartate Aminotransferase Reagent Kit (AST) Reactive Ingredients Ingredient ConcentrationR1：β-NADH 0.16 mg/mL Malate Dehydrogenase 0.64 U/mL Lactate Dehydrogenase 0.64 U/mL L-Aspartate 232 mmol/LR2：α-Ketoglutarate 51.3 mmol/L L-Aspartate 100 mmol/L

• 關聯藥證數量: 1

Assay Drug Multi DOA Verifier I (ng/mL) Opiates 300 Cal (ng/mL) Multi DOA Cutoff Cal (ng/mL) Multi DOA Verifier II (ng/mL)\nAmphetamine d-Methamphetamine 0 300 1,000 2,000\nBarbiturates Secobarbital 0 200 800\nBenzodiazepines Lormetazepam 0 200 1,000\nCannabinoids 11-non-△9-THC-9-COOH 0 50 200 0 50 200\nCocaine Benzoylecgonine 0 300 1,000\nMethadone Methadone 0 300 1,000\nMethaqualone Methaqualone 0 300 1,000\nOpiates Morphine 0 300 2,000 4,000\nPhencyclidine Phencyclidine 0 25 100\nPropoxyphene Propoxyphene 0 300 1,000\n\n

• 關聯藥證數量: 1

Assay Buffer：Poluethylene Glycol 6%(w/v)\n Tris/HCI buffer 20 mmol/l, pH 7.4\n Sodium Chloride 150 mmol/l\nAntibody Reagent：Anti(human) albumin \n Tris/HCI buffer 20 mmol/l, pH 7.4\n Sodium Chloride 150 mmol/l\n Standards nominally 0-200 mg/l\n Human serum albumin

• 關聯藥證數量: 1

Assay Diluent：1 Bottle (10.0 mL) Assay Diluent containing MES buffer with surfactant and protein blockers.

• 關聯藥證數量: 1

Assay Diluent：1 or 4 Bottles (10.0 mL each) Assay Diluent containing MES buffer and NaCl.

• 關聯藥證數量: 1

Assay Diluent：1 or 4 Bottles (10.0 mL/50.9 mL) Troponin-I Assay Diluent, containing protein stabilizers in phosphate buffer.

• 關聯藥證數量: 1

Assay Plate and Cover 1 each\nSample Diluent 1 x 25 ml\nStimulant (PHA-L) 1 x 1.8 ml\nDynabeads CD4 1 x 6.5 ml\nWash Buffer 1 x 125 ml\nLysis Reagent 1 x 50 ml\nCalibrator Panel 5 levels x 0.8 ml each \nLuminescence Reagent 1 x 33 ml\nMeasurement Plate 2 each

• 關聯藥證數量: 1

Assay by HPLC: Terbinafine Hydrochloride contains not less than 98.0% and not more than 102.0% of C21H25N.HCl calculated on dried basis.

• 關聯藥證數量: 1

Assay：Imipenem contains not less than 42.5% and not more than 48% of labeled amounts of Imipenem C12H17N3O4S calculated on anhydrous basis.\nCilastatin contains not less than 42.5% and not more than 48% of labeled amounts of Cilastatin C16H26N2O5S calculated on anhydrous basis.

• 關聯藥證數量: 1

Assay：Methylprednisolone Sodium Succinate sterile buffered contains not less than 97.0% and not more than 103.0% of C26H33NaO8 calculated phosphates free, dried substance.

• 關聯藥證數量: 1

Asunaprevir

• 關聯藥證數量: 1

Atenolol contains 99.0% to 101.0% of atenolol (C14H22N2O3), calculated on the dried substance.

• 關聯藥證數量: 1

Atenolol contains not less than 98.0 percent and not more than 102.0 percent of C14H22N2O3, calculated on the dried basis.

• 關聯藥證數量: 1

Atenolol contains not less than 99.0% and not more than 101.0% of C14H22N2O3, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Atenolol contains not less than 99.0% and not more than the equivalent of 101.0% of 2-[4-[(2RS)-2-hydroxy-3-[(1-methylethyl) amino] propoxy]phenyl]acetamide, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Atomoxetine Hydrochloride contains 98.0% ~102.0% of C17H21NO‧HCl, calculated on the dried basis.

• 關聯藥證數量: 1

Atomoxetine Hydrochloride content: Assay (HPLC, wt%): 98.0%~102.0% (dried basis)

• 關聯藥證數量: 1

Atomoxetine Hydrochloride contians not less than 99.0% and not more than 102.0% of C17H21NO‧HCl, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Atorcastatin Calcium Trihydrate contains not less than 97.0% and not more than 102.0% of C66H68CaF2N4O10‧3H2O calculated on the anhydrous substance.

• 關聯藥證數量: 1

Atorvastatin Calcium (Amorphous) contains not less than 98.0% and not more than 102.0% of C66H68CaF2N4O10 calculated on the dried basis.

• 關聯藥證數量: 1

Atorvastatin Calcium Trihydrate (Micronised) Content: 97.0% to 102.0% (Anhydrous substance).

• 關聯藥證數量: 1

Atorvastatin Calcium Trihydrate contains not less than 98.0% and not more than 102.0% of (C33H34FN2O5)2 Ca‧3H2O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Atorvastatin Calcium Trihydrate contains not less than 98.0% and not more than 102.0% of C66H68CaF2N4O10‧3H2O, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Atorvastatin Calcium contains 97.0 percent to 102 percent of C66H68CaF2 N4O10‧3H2O, calculated on anhydrous substance.

• 關聯藥證數量: 1

Atorvastatin Calcium contains not less than 97.0 percent and not more than 102.0 percent of C66H68CaF2N4O10,3H2O, calculated on the dried basis.

• 關聯藥證數量: 1

Atorvastatin Calcium contains not less than 98.0% and not more than 102.0% of C66H68CaF2N4O10 ,calculated on the dried basis.

• 關聯藥證數量: 1

Atorvastatin Calcium contains not less than 98.0% and not more than 102.0% of C66H68CaF2N4O10‧3H2O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Atorvastatin Calcium contains not less than 98.0% and not more than 102.0% of atorvastatin calcium (C66H68CaF2N4O10), calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Atorvastatin Calcium contains：98.0% to 102.0%, of (C66H68F2N4O10Ca), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Atorvastatin calcium (Form I) contains not less than 98.0% and not more than 101.0% of C66H68CaF2N4O10‧3H2O, on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Atorvastatin calcium Trihydrate not less than 97.0% and not more than 102.0% of C66H68CaF2N4O10‧3H2O calculated on the anhydrous substance.

• 關聯藥證數量: 1

Atorvastatin calcium trihydrate (Form I ) contains not less than 98.0% and not more than 102.0% of C66H68CaF2N4O10‧3H2O on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Atractylodes Lancea Rhizome Extract

• 關聯藥證數量: 1

Atropine Sulfate contains NLT 98.0% and not NMT 102.0% of atropine sulfate (C17H23NO3)2‧H2SO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Atropine Sulfate contains not less than 98.5% and not more than 101.0% of (C17H23NO3)2‧H2SO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Atropine Sulfate contains not less than 99.0% and not more than 101.0% (snhydrous substance).

• 關聯藥證數量: 1

Atropine Sulfate contains not less than 99.0% and not more than 101.0% of (C17H23NO3)2・H2SO4・H2O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Atropine Sulfate contains: 99.0% to 101.0% (anhydrous substance).

• 關聯藥證數量: 1

Atropine Sulfate contains：99.0% 101.0% (anhydrous substance).

• 關聯藥證數量: 1

Atropine contains not less than 99.0% and not more than 101.0% of C17H23NO3, calculated on the dried substance.

• 關聯藥證數量: 1

Auramine-Rhodamine：1% Auramine O, 0.5% Rhodamine B, 7.4 % Phenol, 55.5% glycerol\nAcid Alcohol：0.5% HCl in 70% Ethanol\nConunterstain：0.5% Potassium permanganate

• 關聯藥證數量: 1

Auto D-dimer Diluent, #A 8719 0.85% saline solution (2x4 ml).\nAuto D-dimer Calibrator, #A 7971 Lyophilized human plasma enriched with fibrin D-dimer. Refer to the Calibrator Insert for the assigned value of the calibrator. (2x1 ml).

• 關聯藥證數量: 1

Auto D-dimer Reagent, #A 4592 Buttered solution of polystyrene microparticle beads coated with mouse monoclonal antibody MA-8D3 directed against D-dimer. Contains stabilizers and 0.095% sodium azide as a preservative, (4x2 ml).\nAuto D-dimer Reaction Buffer #A 4717 Buffer with stabilizers, pH 7.0 Sodium azide, 0.095%, added as preservative, (4x2 ml).

• 關聯藥證數量: 1

AutoVue Innova, Personal Computer, Touch Screen Monitor, Barcode Scanner, Innova Software CD, Volume QC Microplate, Training Ref Guide

• 關聯藥證數量: 1

Avalglucosidase alfa

• 關聯藥證數量: 1

AxSYM Anti-Tg Reagent Pack\n1 Bottle (9.7mL) purified thyroglobulin (human thyroid tissue extract) coated microparticles in TRIS buffer with protein (bovine) stabilizer. \n1 Bottle (9.8mL) Anti-Human IgG (goat): Alkaline Phosphatase Conjugate in TRIS buffer with protein (bovine) stabilizers.\n1 Bottle (28.7mL) Assay Diluent in TRIS buffer with protein (bovine) stabilizers.\n1 Bottle (35.5mL) Specimen Dilution Buffer in Phosphate buffer.\nAxSYM Anti-Tg Standard Calibrators\n6 Bottles (4.0mL each) at conc. of 0.0, 25.0, 125.0, 250.0, 500.0 and 1000.0 IU/mL, \nAxSYM Anti-Tg Controls\n2 Bottles (7.0mL each) at conc. of 0.0 and 150.0 UL/mL.

• 關聯藥證數量: 1

AxSYM CMV IgM Reagent Pack, 100 Tests\n．1 Bottle (8.9ml) Microparticles Coated with Cytomegalovirus Recombinant Proteins purified from E. coli in TRIS buffer with protein (bovine) stabilizers.\n．1 Bottle (9.6ml) Anti-Human IgM (μ-Specific)(Goat) : Alkaline Phosphatase Conjugate in TRIS buffer with protein (bovine) stabilizers.\n．1 Bottle (28.1ml) Assay Diluent in TRIS buffer with protein (bovine) stabilizers.\nAxSYM CMV IgM Index Calibrator\nINDEX CAL\n1 Bottle (3 ml) CMV IgM Index Calibrator prepared with anti-CMV IgM (human) prepared in human serum, nonreactive for HBsAg, HIV-1 Ag, anti-HIV-1/HIV-2, by licensed tests.\nAxSYM CMV IgM Controls\n1 Bottle (5 ml) Negative Control prepared with human serum, nonreactive for HBsAg, HIV-1 Ag, anti-HCV, and anti-HIV-1/HIV-2, by licensed tests\n1 Bottle (5 ml) Positive Control prepared with anti-CMV IgM (human) in human serum, nonreactive for HBsAg, HIV-1 Ag, anti-HCV, and anti-HIV-1/HIV-2, by licensed tests.

• 關聯藥證數量: 1

AxSYM 125 Reagent reagent Pack 1. 1 Bottle (9.8mL) Anti-Cal125 coated Microparticels in TRIS buffer. 2. 1 Bottle (16.8mL) OC125 Antibody: Alkaline Phosphatase Conjugate in TRIS buffer with protein (bovine and murine) stabilizers. 3. 1 Bottle (34mL) Speciment Diluent, TRIS bueffer with serum. 6 Bottles (4mL each) of CA 125 Standard Calibrators. Calibrator A contains TRIS buffer, CAL A~F concentration: 0, 15, 50, 125, 375 and 600 U/mL. 3 Bottles (8mL each) of CA 125 Controls with OC125 reactive determinants prepare in TRIS buffer with protein (bovine) stabilizers, CA 125 value 30, 80 and 200 U/mL. 1 Bottles (100mL) Speciment Diluent, TRIS buffered sheep serum.

• 關聯藥證數量: 1

AxSYM AFP Reagent Pack 1. 1 Bottle (7.0 mL)Anti-AFP(Mouse,Monoclonal)Coated Microparticles 2. 1 Bottle (13.2 mL)Anti-AFP(Mouse,Monoclonal) ：Alkaline Phosphatase Conjugate 3.1 Bottle (23.6 mL)Specimen Diluent 4.1 Bottle (45.2 mL)Specimen Diluent(For Autodilutions) AFP Calibrators 6 Bottles (4 mL each) of AFP Calibrators：0, 15, 50, 100, 200, 300 ng/mL AFP Controls 3 Bottles (8 mL each) of AFP Controls,L, M, and H：20, 80, 175 ng/mL AxSYM AFP Specimen Diluent 1 Bottles (100 mL) AxSYM AFP Specimen Diluent

• 關聯藥證數量: 1

AxSYM AUSAB reagent Pack*1 Bottle (3.5 ml) Hepatitis B Surface Antigen (Recombinant)(Subtypes ad and ay) Coated Microparticles Minimum concentration:0.05%, 1 Bottle (13.6 ml) Anti-Biotin(Rabbit): Alkaline Phosphatase Conjugate. Minimum concentration: 0.05 ug/ml, 1 Bottle (13.5 ml) Hepatitis B Surface Antigen (Recombinant)(Subtypes ad and ay): Biotin Conjugate. Minimum concentration: 1 ug/ml, 1 Bottle(31.4 ml) Dilution Reagent. Recalcified human plasma, AxSYM AUSAB Standard Calibrator Six bottles (4 ml each) of Standard Calibrators are prepared with recalcified human plasma, AxSYM AUSAB Controls Two bottles (8 ml each) of Controls are prepared with recalcified human plasma, AxSYM AUSAB Dilution Reagent 1 bottle (100ml) AxSYM AUSAB Dilution Reagent are prepared with recalcified human plasma, AxSYM Probe Cleaning Solution 4 bottles (110ml each) containing 2% TEAH, Solution 1 (MUP) 4 bottles (230 ml each) containing 1.2 mM 4-Methylumbelliferyl Phosphate, Solution 3 (Matrix Cell Wash) 4 bottles (1000 ml each) containing 0.3M NaCl in Tris buffer, Solution 4 (10L) containing 0.1M Phosphate Buffer

• 關聯藥證數量: 1

AxSYM Anti-HBe 2.0 Reagent Pack1. 1 Bottle(6.3ml) Antibody to Hepatits B e Antigen (Mouse, Monoclonal) Coated microparticles in TRIS buffer with protein stabilizers. Minimum concentration: 0.005% solids. Preservative: Sodium azide.2. 1 Bottle (10.9ml) Antibody to Hepatitis B e Antigen (Mouse, Monoclonal):Alkaline Phosphate Conjugate in TRIS buffer with protein stabilizers. Minimum concentration: 0.1ug/ml. Preservatives: Sodium azide and antimicobial agents.3. 1 Bottle (28.1ml) Neutralizing reagent. Hepatitis B e Antigen (recombinant DNA) in TRIS buffer with protein stabilizers. Minimum concentration:100.5PEI U/ml. Preservative:Sodium azide.4. 1 Bottle (50.2ml) Specimen diluent containing sodium chloride in TRIS buffer. Preservatives: Sodium azide and antimicrobial agents.1 Bottle(4ml) AxSYM Anti-HBe 2.0 Index Calibrator. Racalcified human plasma, nonreactive for anti-HBe,HbeAg, HBsAg,HIV-1 Ag, anti-HCV and HIV-1/2, by FDA licensed or approved tests.Preservative: Sodium azide.AxSYM Anti-HBe

• 關聯藥證數量: 1

AxSYM Anti-TPO Reagent Pack\n1 Bottle (10.6mL) purified thyroid peroxidase (from human thyroid glands) coated microparticles in TRIS buffer with protein (bovine) stabilizers.\n1 Bottle (9.8mL) Anti-Human IgG (goat):Alkaline Phosphatase Conjugate in TRIS buffer with protein (bovine) stabilizers.\n1 Bottle (28.7mL) Assay Diluentin TRIS buffer with protein (bovine) stabilizers.\n1 Bottle (35.5mL) Specimen Dilution Buffer in Phosphate Buffer.\n6 Bottle (4.0mL each)of AxSYM Anti-TPO Standard Calibrators. (0~1000 IU/mL)\n2 Bottles (7.0mL each) of AxSYM Anti-TPO Controls. (0, 75 IU/mL)

• 關聯藥證數量: 1

AxSYM CA 19-9 Reagent Pack 1 Bottle(7.0 mL)111-6-NS-19-9 (Mouse,Monoclonal)Coated Microparticles 1 Bottle(8.8 mL)Assay Diluent 1 Bottle(15.1 mL)111-6-NS-19-9 (Mouse,Monoclonal)：Alkaline Phosphatase Conjugate Six bottles(4 mL each) of AxSYM CA 19-9 Standard Calibrators A-F, in 0, 30, 90, 180, 320 and 500 U/mL Three bottles (8 mL each) of AxSYM CA 19-9 Controls L, M and H in 40, 125 and 250 U/mL. 1 Bottle(100 mL) AxSYM CA 19-9 Specimen Diluent

• 關聯藥證數量: 1

AxSYM CA15-3 Specimen Diluent 1 Bottles (100mL) of Specimen Diluent TRIS buffer with protein (bovine and murine)stabilizers.

• 關聯藥證數量: 1